Form 4: Verisk Analytics CFO Sells Shares Under 10b5-1 Plan

Verisk Analytics Chief Financial Officer Elizabeth Mann sold 400 shares of common stock for $179.54 per share, totaling $71,816, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Elizabeth Mann, Chief Financial Officer of Verisk Analytics, Inc., reported a transaction involving the sale of 400 shares of common stock.
• The sale occurred on June 15, 2026, at a price of $179.54 per share, resulting in a total transaction value of $71,816.
• These shares were sold under a Rule 10b5-1 trading plan, which Ms. Mann had entered into on December 11, 2025.
• Following this transaction, Ms. Mann beneficially owns 19,184 shares of Verisk Analytics common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it involves a sale by a key executive, the use of a 10b5-1 plan mitigates concerns about opportunistic selling, and the remaining beneficial ownership is substantial.

Positives

• The sale was executed under a Rule 10b5-1 plan, indicating a pre-determined and structured approach to stock sales, which can mitigate insider trading concerns.
• The transaction was a sale of a relatively small number of shares (400), suggesting it may not represent a significant divestment of the CFO's holdings.
• The CFO continues to beneficially own a substantial number of shares (19,184) after the sale.

Negatives

• A sale of company stock by a high-ranking executive, even under a 10b5-1 plan, can sometimes be perceived negatively by the market.
• The sale represents a reduction in the CFO's direct beneficial ownership of the company's stock.

Risks

• The primary risk associated with this type of filing is the potential for negative market perception of insider selling, regardless of the structured nature of the sale.
• Future sales under the 10b5-1 plan could further reduce the CFO's direct holdings, potentially signaling a lack of confidence if not managed carefully.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. The only forward-looking aspect is the existence of the 10b5-1 plan, which allows for future transactions under pre-defined conditions.

Management Comments

• The sale was conducted pursuant to a Rule 10b5-1 plan entered into on December 11, 2025.

Industry Context

StockSavvy.ai notes that Form 4 filings, particularly those involving sales by C-suite executives, are closely watched by investors. The use of a 10b5-1 plan is a standard practice for executives to diversify their holdings or manage personal financial needs while adhering to insider trading regulations. The price of $179.54 per share reflects the current market valuation of Verisk Analytics.

Stakeholder Impact

• Shareholders: May interpret the sale as a minor negative signal, though mitigated by the 10b5-1 plan. The continued substantial ownership by the CFO should provide some reassurance.
• Employees: Similar to shareholders, the impact is likely minimal given the structured nature of the sale.
• Creditors/Suppliers: No direct impact expected from this transaction.

Next Steps

• Continued monitoring of future Form 4 filings from Verisk Analytics executives to observe any further transactions under the 10b5-1 plan or other trading activities.
• Analysis of Verisk Analytics' upcoming financial reports and strategic announcements for broader company performance indicators.

Key Dates

Recommendation

The filing reports a routine stock sale by the CFO under a pre-established 10b5-1 plan. While insider selling can be a concern, the structured nature of this transaction and the executive's continued significant beneficial ownership suggest it is not indicative of a negative outlook for Verisk Analytics. Therefore, a 'hold' recommendation is appropriate, pending further company performance data.

Keywords

Verisk Analytics, VRSK, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Elizabeth Mann, CFO, Beneficial Ownership, Securities Exchange Act